insulin resistance and tirzepatide Novel Dual Incretin Receptor Agonists in the Spectrum of Metabolic Diseases with a Focus on Tirzepatide: Real Game-Changers or Great Expectations? A Narrative Review Understanding Prediabetes, Insulin Resistance, &

In traditional clinical trials, a "responder" is someone who loses at least 5% of their body weight within the first three to six months

IV ozone therapy can be used to treat wounds, infections, rheumatoid arthritis, lupus, and numerous other diseases

IBI362 (LY3305677), a weekly-dose GLP-1 and glucagon receptor dual agonist, in Chinese adults with overweight or obesity: a randomised, placebo-controlled, multiple ascending dose phase 1b study

And we know theres bone loss that accompanies weight loss with these medications

They also delay the emptying of your stomach, making you feel fuller for longer

This article analyzes the costs and benefits of health plan coverage of GLP-1s